|
14 Jan 2020 |
News |
Diabetics using SGLT2 Inhibitors have a lower Gout Risk |
|
|
02 Jan 2020 |
Social |
Internet based study by Choi et al - looked at 517 gout patients and examined if gout flares were associated with vaccination. They found a twofold higher odds of gout flare (adjusted OR 1.99; 95% CI 1.01 to 3.89 in those who were vaccinated (any vaccine). https://t.co/dSkG6d1ay5 |
|
|
01 Jan 2020 |
Social |
Can Febuxostat be given to Allopurinol Hypersensitivity? Such pts not included in registrations trials; yet many literature reports of no toxicity & rare cross-Rxn; PI says ULORIC indicated w/ intolerance to allopurinol or when allopurinol Tx not advisable https://t.co/Wyax2XZ8cC |
|
|
28 Dec 2019 |
Social |
RT @Tuhina_Neogi: Should we keep our patients with #gout on colchicine indefinitely (if no contraindications/intolerances) for their higher… |
|
|
18 Dec 2019 |
Social |
In Southern Sweden, the prevalence of non-gout crystal arthropathy (>1/3 of which was CPPD) is 0.23%, w/ meage of 71 yrs, more in men and increases w/ age. The incidence is 21.5 (19–25) cases/100,000 persons. https://t.co/MLIhxBPUSO |
|
|
17 Dec 2019 |
News |
A Role for SGLT2 Inhibition in Gout? |
|
|
13 Dec 2019 |
News |
Predicting Inpatient Gout Flares |
|
|
12 Dec 2019 |
Social |
Caltech researchers developed a wearable sensor that detects & monitors uric acid levels. Shown to be elevated in both gout patients and normals after purine rich meals. Cool technology thats still a long way from commercial use. https://t.co/jeLfb1Vbz0 https://t.co/TMVkIGPWE1 |
|
|
04 Dec 2019 |
Social |
Ultrasound study of 980 #gout pts finds Bone erosions were seen in 44%, with 78.4% of these found in the first metatarsophalangeal (MTP) joint. Independent predictors include age, duration of gout, tophi, US synovitis and and joint effusion. https://t.co/LxjgfM29Xd |
|
|
03 Dec 2019 |
Social |
RT @ACRheum: ACR/ARP 2019 attendees get “sneak preview” of updated gout clinical practice guideline → https://t.co/VRyfj75nVu #ACR19 |
|
|
30 Nov 2019 |
Social |
RT @RheumatologyNet: Gout Attacks Intensify with Heart Failure #cardiovascular https://t.co/LxCw8sCv5P https://t.co/ZukMrWuaeF |
|
|
29 Nov 2019 |
Social |
I didn’t realize how fast Pegloticase works. Assuming the urate burden of a gout patient, Pegloticase can degrade all the urate in the body over 5-40 days!
#ACR19 3S050 Lipsky @_connectedcare |
|
|
29 Nov 2019 |
Social |
Crossreactivity events between allopurinol rashes and febuxostat are very low https://t.co/jVVQhtB0CK |
|
|
29 Nov 2019 |
Social |
New package labeling says febuxostat should only be considered after allopurinol has been tried or is contraindicated. https://t.co/Sk2MhEiOhv |
|
|
29 Nov 2019 |
Social |
PANLAR KOL recommendations for MSUS in gout clinic. Abs #301 https://t.co/uziDzNM0VX #ACR19 @uptoTate
@RheumNow |
|
|
25 Nov 2019 |
News |
Pegradicase+ImmTOR SEL-212 Shows Promising Results In Active Gout |
|
|
21 Nov 2019 |
Social |
The draft 2020 ACR #gout guidelines were presented at the last slot of the meeting. Big changes for ULT initiation #ACR19 @philipcrobinson [Slides attached] https://t.co/4g3YUlm7Sa |
|
|
20 Nov 2019 |
News |
PANLAR Ultrasound Study Group: Recommendations On Imaging Modalities In Gout |
|
|
20 Nov 2019 |
ACR Video |
Overview of Several Gout Studies: Dr. Philip Robinson |
|
|
20 Nov 2019 |
ACR Video |
Gout Studies at ACR: Dr. Guillermo Valenzuela |
|
